| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ahmad K Al-Khazaleh, Xian Zhou, Deep Jyoti Bhuyan, Gerald W Münch, Elaf Adel Al-Dalabeeh, Kayla Jaye, Dennis Chan. The Neurotherapeutic Arsenal in Molecules (Basel, Switzerland). vol 29. issue 2. 2024-01-23. PMID:38257323. |
terpenes, aromatic compounds imbuing distinct flavours, not only contribute to cannabis's sensory profile but also modulate cannabinoid effects through diverse molecular mechanisms. |
2024-01-23 |
2024-01-25 |
Not clear |
| Ahmad K Al-Khazaleh, Xian Zhou, Deep Jyoti Bhuyan, Gerald W Münch, Elaf Adel Al-Dalabeeh, Kayla Jaye, Dennis Chan. The Neurotherapeutic Arsenal in Molecules (Basel, Switzerland). vol 29. issue 2. 2024-01-23. PMID:38257323. |
this review underscores the imperative to delve into the intricate roles of cannabinoids, terpenes, and flavonoids, offering promising prospects for innovative therapeutic interventions and advocating continued research to unlock cannabis's full therapeutic potential within the realm of natural plant-based medicine. |
2024-01-23 |
2024-01-25 |
Not clear |
| Valerio Ricci, Ilenia Di Muzio, Franca Ceci, Francesco Di Carlo, Gianluca Mancusi, Tommaso Piro, Andrea Paggi, Mauro Pettorruso, Federica Vellante, Domenico De Berardis, Giovanni Martinotti, Giuseppe Main. Aberrant salience in cannabis-induced psychosis: a comparative study. Frontiers in psychiatry. vol 14. 2024-01-23. PMID:38260781. |
natural cannabis (nc) and synthetic cannabinoids (scs) use can increase the risk and exacerbate the course of psychotic disorders. |
2024-01-23 |
2024-01-25 |
Not clear |
| Brooke Manning, Luke A Downey, Andrea Narayan, Amie C Hayle. A systematic review of oculomotor deficits associated with acute and chronic cannabis use. Addiction biology. vol 29. issue 1. 2024-01-15. PMID:38221807. |
cannabis selectively influences oculomotor activity relevant to driving, highlighting the role of cannabinoid systems in these processes. |
2024-01-15 |
2024-01-17 |
Not clear |
| Nicole Esdar, Evelyn Pawlik, Simon B Eickhoff, Annika Raupach, Stefanie Ritz-Timme, Felix Maye. Cardiac effects of 5F-Cumyl-PEGACLONE. International journal of legal medicine. 2024-01-12. PMID:38214738. |
synthetic cannabinoids become increasingly popular as a supposedly safe and legal alternative to cannabis. |
2024-01-12 |
2024-01-14 |
rat |
| Feng-Xin Chu, Xiao Wang, Bo Li, Li-Li Xu, Bin D. The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 2024-01-09. PMID:38191853. |
unlike tetrahydrocannabinol, cannabidiol has a lower affinity for cannabinoid receptors, which may be the reason why it is not psychoactive. |
2024-01-09 |
2024-01-10 |
Not clear |
| Kristiina Kinnunen, Linda E Robayo, Nicholas P Cherup, Scott I Frank, Eva Widerström-Nog. A preliminary study evaluating self-reported effects of cannabis and cannabinoids on neuropathic pain and pain medication use in people with spinal cord injury. Frontiers in pain research (Lausanne, Switzerland). vol 4. 2024-01-08. PMID:38188193. |
a preliminary study evaluating self-reported effects of cannabis and cannabinoids on neuropathic pain and pain medication use in people with spinal cord injury. |
2024-01-08 |
2024-01-10 |
human |
| Kristiina Kinnunen, Linda E Robayo, Nicholas P Cherup, Scott I Frank, Eva Widerström-Nog. A preliminary study evaluating self-reported effects of cannabis and cannabinoids on neuropathic pain and pain medication use in people with spinal cord injury. Frontiers in pain research (Lausanne, Switzerland). vol 4. 2024-01-08. PMID:38188193. |
increasingly, the potential analgesic effects of cannabis and cannabinoid products have been studied; however, little research has been conducted among those with sci-related neuropathic pain. |
2024-01-08 |
2024-01-10 |
human |
| Kristiina Kinnunen, Linda E Robayo, Nicholas P Cherup, Scott I Frank, Eva Widerström-Nog. A preliminary study evaluating self-reported effects of cannabis and cannabinoids on neuropathic pain and pain medication use in people with spinal cord injury. Frontiers in pain research (Lausanne, Switzerland). vol 4. 2024-01-08. PMID:38188193. |
therefore, the primary objective of the study was to investigate the perceived effects of cannabis and cannabinoid use on neuropathic pain among those who were currently or had previously used these approaches. |
2024-01-08 |
2024-01-10 |
human |
| Kristiina Kinnunen, Linda E Robayo, Nicholas P Cherup, Scott I Frank, Eva Widerström-Nog. A preliminary study evaluating self-reported effects of cannabis and cannabinoids on neuropathic pain and pain medication use in people with spinal cord injury. Frontiers in pain research (Lausanne, Switzerland). vol 4. 2024-01-08. PMID:38188193. |
additionally, the study aimed to determine if common pain medications are being substituted by cannabis and cannabinoids. |
2024-01-08 |
2024-01-10 |
human |
| Nicole Rodrigues Silva, Francisco Isaac Fernandes Gomes, Alexandre Hashimoto Pereira Lopes, Isadora Lopes Cortez, Jéssica Cristina Dos Santos, Conceição Elidianne Aníbal Silva, Raphael Mechoulam, Felipe Villela Gomes, Thiago Mattar Cunha, Francisco Silveira Guimarãe. The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPARγ Receptors. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. vol 19. issue 1. 2024-01-04. PMID:38176808. |
several studies have shown the therapeutic potential of cannabinoids, including cannabidiol (cbd), the major non-psychotomimetic compound found in the cannabis plant, to treat peripheral neuropathies. |
2024-01-04 |
2024-01-07 |
mouse |
| Azhar Hussain, Sistu Kc, Fnu Sapn. Cannabinoid-Associated Hyperemesis Syndrome Treated With Dronabinol: Killing a Poison With the Poison. Cureus. vol 15. issue 11. 2024-01-01. PMID:38161894. |
cannabinoid hyperemesis syndrome (chs) is a medical condition characterized by recurrent nausea, vomiting, and abdominal pain in individuals who frequently use cannabis. |
2024-01-01 |
2024-01-05 |
Not clear |
| Sayuri Suzuki, Clay Wakano, Mahealani K Monteilh-Zoller, Aaron J Cullen, Andrea Fleig, Reinhold Penne. Cannabigerolic Acid (CBGA) Inhibits the TRPM7 Ion Channel Through its Kinase Domain. Function (Oxford, England). vol 5. issue 1. 2024-01-01. PMID:38162115. |
cannabinoids are a major class of compounds produced by the plant cannabis sativa. |
2024-01-01 |
2024-01-05 |
mouse |
| Sayuri Suzuki, Clay Wakano, Mahealani K Monteilh-Zoller, Aaron J Cullen, Andrea Fleig, Reinhold Penne. Cannabigerolic Acid (CBGA) Inhibits the TRPM7 Ion Channel Through its Kinase Domain. Function (Oxford, England). vol 5. issue 1. 2024-01-01. PMID:38162115. |
previous work has demonstrated that the main cannabinoids cannabidiol (cbd) and tetrahydrocannabinol (thc) can have some beneficial effects on pain, inflammation, epilepsy, and chemotherapy-induced nausea and vomiting. |
2024-01-01 |
2024-01-05 |
mouse |
| Evangelos Dadiotis, Meng Cui, Maria Gerasi, Vangelis Mitsis, Eleni Melliou, Alexandros Makriyannis, Diomedes E Logothetis, Prokopios Magiati. A Simple Chiral Journal of natural products. 2023-12-29. PMID:38158562. |
cannabichromene is one of the well-known cannabinoids found in cannabis, along with thc (tetrahydrocannabinol) and cbd (cannabidiol). |
2023-12-29 |
2024-01-05 |
Not clear |
| Leah Sera, Carrie Hempel-Sanderof. Cannabis Science and Therapeutics: An Overview for Clinicians. Journal of clinical pharmacology. 2023-12-25. PMID:38145388. |
in addition, the review addresses the practical considerations of using cannabis as a therapeutic agent, offering insights into dosing strategies, variations in cannabinoid formulation, and individual patient responses. |
2023-12-25 |
2023-12-27 |
Not clear |
| Magdalena Chłopecka, Łukasz Kiraga, Kijan Crowley, Michał Jank, Urszula Latek, Marta Mendel, Wojciech Karli. Diclofenac and dexamethasone modulate the effect of cannabidiol on the rat colon motility Journal of veterinary research. vol 67. issue 2. 2023-12-25. PMID:38143819. |
diclofenac and dexamethasone modulate the effect of cannabidiol on the rat colon motility due to the growing interest in the use of cannabinoids in supportive therapies, they are increasingly used together with anti-inflammatory drugs. |
2023-12-25 |
2023-12-27 |
rat |
| Omayma Alshaarawy, Gokulakrishnan Balasubramanian, Thangam Venkatesa. Cannabis use in the United States and its impact on gastrointestinal health. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2023-12-24. PMID:38142306. |
here, we review evidence of the gastrointestinal (gi) effects of cannabis and cannabinoids. |
2023-12-24 |
2023-12-25 |
Not clear |
| Omayma Alshaarawy, Gokulakrishnan Balasubramanian, Thangam Venkatesa. Cannabis use in the United States and its impact on gastrointestinal health. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2023-12-24. PMID:38142306. |
yet, chronic heavy cannabis use has been linked to recurrent episodes of severe nausea and intractable vomiting (cannabinoid hyperemesis syndrome). |
2023-12-24 |
2023-12-25 |
Not clear |
| Omayma Alshaarawy, Gokulakrishnan Balasubramanian, Thangam Venkatesa. Cannabis use in the United States and its impact on gastrointestinal health. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2023-12-24. PMID:38142306. |
given the considerable heterogeneity in the scientific literature, it is unclear if cannabinoid hyperemesis syndrome is truly a distinct entity or a subtype of cyclic vomiting that is unmasked by heavy cannabis use and the associated dysregulation of the endocannabinoid system. |
2023-12-24 |
2023-12-25 |
Not clear |